MoFo Reps Terumo In $2.6B Gambro Unit Deal

Law360, New York (March 7, 2011, 3:04 PM EST) -- Japanese medical technology heavyweight Terumo Corp. agreed Monday to purchase Swedish medical device maker Gambro AB's Colorado-based blood product unit, CaridianBCT, for $2.6 billion.

The deal is expected to add 70 billion yen ($850 million) to Terumo's annual sales, and is part of the company's strategy to achieve revenues of $12.2 billion within 10 years, according to a statement from the companies filed with the Tokyo Stock Exchange.

A spokesman from Morrison & Foerster LLP, which represented Terumo in the deal, said it was the biggest...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.